Titlebook: Unmanned Rotorcraft Systems; Guowei Cai,Ben M. Chen,Tong Heng Lee Book 2011 Springer-Verlag London Limited 2011 Aerial Vehicles.Aerodynami

Compass

WATER

esize key aspects of management.Incisive evaluation of complA clinical case-based handbook has a role in general clinicians’ practice of caring for patients with serious or life-limiting illness. The explosion of the field of Hospice and Palliative Medicine impacts all physicians and healthcare prov

BET

Mri485

Guowei Cai,Ben M. Chen,Tong Heng Leeular. It starts with the crucial but difficult distinction between utility and futility of technology as well as the question of when to start and when to stop treatment. These issues go to the ethical core of medicine, i.e., to do good and avoid doing harm. Given the vast potential of modern techno

Commemorate

Guowei Cai,Ben M. Chen,Tong Heng Leed format.Written by an interdisciplinary team of expertsThis book provides a comprehensive, state-of-the-art overview on palliative care for patients?with hematologic malignancies and other serious blood disorders. The text reviews the unique needs of this patient population, management strategies f

micturition

Guowei Cai,Ben M. Chen,Tong Heng Leeely debilitating dyspnea and systemic symptoms that reduce quality of life and result in high acute care utilization near the end of life. Despite recommendations to integrate specialist palliative care in COPD and the proven benefits of its early integration in the care of patients with advanced ca

disparage

Guowei Cai,Ben M. Chen,Tong Heng Lee palliative needs. Most patients with . present with advanced, symptomatic disease. The great majority of these patients cannot be cured, and they have limited treatment options. Except for a few patients with molecular targets for drugs, they have to rely on chemotherapy and radiotherapy, which onl

一致性

Guowei Cai,Ben M. Chen,Tong Heng Leet adults who understand that their cancer is incurable are less likely to continue cytotoxic cancer-directed therapy. However, novel classes of targeted and immunologic therapies are rapidly changing treatment paradigms in advanced malignancies. These agents may alter previously accepted prognostic

審問,審訊

Latency